CStone Pharmaceuticals
Hongyan H. has over 13 years of work experience in the pharmaceutical industry. Hongyan started their career at PAREXEL as a Clinical Operations Manager in March 2007 and worked there until July 2013. Hongyan then joined Covance as a Sr. Clinical Operations Manager in August 2013 and stayed with the company until April 2018. Currently, they are working as the Director of Project Management at a pharmaceutical company since April 2018.
Hongyan H. completed their Bachelor of Medicine degree from Chengde Medical University in 2005. In 2018, they pursued their MBA in Management from East China Normal University, which they completed in 2020.
CStone Pharmaceuticals
CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established at the end of 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. With a strategic emphasis on immuno-oncology combination therapies, the Company has built an oncology-focused pipeline of 16 drug candidates, including 5 late-stage candidates at pivotal trials or registration stages. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone’s vision is to become a world-renowned biopharmaceutical company that is leading the way to conquering cancer.